tirzepatide pcos How works w/ Possible protective effects of tirzepatide

Avoid use in individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2)

SC) was administered into rats for 3 consecutive days, then they were treated daily with semaglutide intraperitoneally in low (5 nmol/kg), intermediate (10 nmol/kg), or high doses (20 nmol/kg), respectively, for 14 consecutive days

Nausea, vomiting, diarrhea, constipation

Stop using the pen and consult your healthcare provider immediately if you develop severe, persistent stomach pain that radiates to your back (a potential sign of pancreas irritation), unexpected changes in vision, severe dizziness, or signs of an acute allergic reaction